Edition:
United States

People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

23.45USD
22 Sep 2017
Change (% chg)

-- (--)
Prev Close
$23.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
858,487
52-wk High
$33.00
52-wk Low
$13.60

Randall, Lorin 

Mr. Lorin Jeffry Randall is an Independent Director of Acorda Therapeutics, Inc. Mr. Randall, a financial consultant, was Senior Vice President and Chief Financial Officer of Eximias Pharmaceutical Corporation, a development-stage drug development company, from 2004 to 2006. From 2002 to 2004, Mr. Randall served as Senior Vice President and Chief Financial Officer of i-STAT Corporation, a publicly-traded manufacturer of medical diagnostic devices that was acquired by Abbott Laboratories in 2004. From 1995 to 2001, Mr. Randall was Vice President and Chief Financial Officer of CFM Technologies, Inc., a publicly-traded manufacturer of semiconductor manufacturing equipment. He currently serves on the boards of directors of Athersys, Inc. where he serves as Chairman of the Audit Committee and Chairman of the Compensation Committee, and Aurinia Pharmaceuticals Inc. In addition, within the last five years, he previously served on the boards of directors of Nanosphere, Inc., Tengion, Inc. and MotoLogic, Inc. Mr. Randall received a B.S. in accounting from The Pennsylvania State University and an M.B.A. from Northeastern University.

Basic Compensation

Total Annual Compensation, USD 73,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 178,766
Fiscal Year Total, USD 251,766

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen

3,433,220

Richard Batycky

--

David Lawrence

1,360,800

Andrew Blight

1,484,560

Jane Wasman

1,986,540

Burkhard Blank

3,521,550
As Of  30 Dec 2016